Atea Pharmaceuticals Starts Phase 1 AT-587 Trial
BOSTON, July 14, 2026 Atea Pharmaceuticals announced the initiation of a first-in-human Phase 1 clinical trial evaluating AT-587, an...
antiviral therapy
Advertisement
Aligos Completes Phase 2 B-SUPREME Enrollment
SOUTH SAN FRANCISCO, Calif., July 13, 2026 Aligos Therapeutics announced the completion of patient enrollment in both parts of...
60 Degrees Pharma Expands Tick-Borne Disease Pipeline
WASHINGTON, July 8, 2026 60 Degrees Pharmaceuticals announced that it has entered into an exclusive option agreement with the...
Aligos Secures $25M Upfront in Greater China Deal
SOUTH SAN FRANCISCO, Calif., July 6, 2026 Aligos Therapeutics has received a $25 million upfront payment from Xiamen Amoytop...
FDA Approves First Generic Xofluza for Influenza Treatment
SILVER SPRING, Md., June 17, 2026 The U.S. Food and Drug Administration (FDA) has approved the first generic version...
Advertisements
Altesa’s Vapendavir Shows Promise in Preventing COPD Flares
WASHINGTON, D.C., June 5, 2026 Altesa BioSciences has unveiled encouraging new Phase 2 clinical findings demonstrating that vapendavir, its...
RedHill Advances Opaganib as Potential Ebola Treatment Amid Rare Bundibugyo Virus Outbreak
TEL AVIV, Israel and RALEIGH, N.C., June 2, 2026 RedHill Biopharma has announced efforts to advance the clinical development...
Galmed and Tissue Dynamics Uncover Novel Pathway in Cardiac Fibrosis
REHOVOT and RAMAT-GAN, Israel, June 2, 2026 Galmed Pharmaceuticals and Tissue Dynamics have announced a significant preclinical breakthrough in...
Alife Health Receives FDA Clearance for AI-Powered Embryo Selection Technology
SAN FRANCISCO, May 28, 2026 Alife Health has achieved a major milestone in reproductive medicine with the U.S. Food...
Ansun Biopharma Advances Phase 3 DAS181 Trial Following Positive DMC Review
SAN DIEGO, June 1, 2026 Ansun Biopharma has announced a significant clinical development milestone after an independent Data Monitoring...
Advertisement
